Intravenous Immunoglobulin for Early Prevention of Cardiopulmonary Bypass Induced Hypogammaglobulinemia in Infants and Neonates
Phase of Trial: Phase II
Latest Information Update: 17 Apr 2019
Price : $35 *
At a glance
- Drugs Immune globulin (Primary)
- Indications Agammaglobulinaemia; Postoperative infections
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 15 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 May 2015 Planned End Date changed from 1 Mar 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.